![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1662, 2008-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram ahead of the rest in MDD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 481, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram ahead of the game in MDD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram ahead of the game in GAD
Inpharma, Vol. 1, Iss. 1567, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram ahead of the game in GAD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Escitalopram saves compared with duloxetine in MDD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 565, 2008-01 ,pp. :